Press

Oct6th2021

Canary RX Announces Year to Date Wholesale Cannabis Sales

NORFOLK COUNTY, ON, Oct. 5, 2021 /CNW/ – Target Group Inc. (OTCQB: CBDY) is pleased to announce that its wholly owned subsidiary, Canary Rx...

Read More

Sep15th2021

Canary RX Receives its Health Canada Sales License

Canary RX Receives its Health Canada Sales License NEWS PROVIDED BY Target Group Inc. Sep 15, 2021, 09:00 ET NORFOLK COUNTY, ON, Sept....

Read More

Feb24th2021

Canary RX Inc. Completes its First 3 Wholesale Transactions of its Cannabis to Multiple Canadian Licensed Producers

NORFOLK COUNTY, ON, Feb. 24, 2021 /PRNewswire/ – Target Group Inc. (OTCQB: CBDY) is pleased to announce that its wholly owned subsidiary, Canary Rx Inc....

Read More

Jun3rd2020

Canary RX Inc. Signs Definitive Agreement with Thrive Cannabis on New Joint Venture Cultivation Opportunity

Canary RX Inc. Signs Definitive Agreement with Thrive Cannabis on New Joint Venture Cultivation Opportunity NEWS PROVIDED BY Canary RX Inc. Jun 03,...

Read More

Oct8th2019

Canary RX Inc., Awarded 3 Licenses from Health Canada to Cultivate, Process and Sell Cannabis Pursuant to the Cannabis Act.

  Canary RX Inc., Awarded 3 Licenses from Health Canada to Cultivate, Process and Sell Cannabis Pursuant to the Cannabis Act. Norfolk County,...

Read More

Aug13th2019

Target Group Inc. signs exclusive licensing, manufacturing, and distribution agreement for patent pending THC antidote, True Focus™

VAUGHAN, ON, Aug. 13, 2019 /PRNewswire/ – Target Group Inc. (“Target Group” or the “Company”) (OTCQB: CBDY) is pleased to announce, that effective...

Read More

Jun19th2019

Target Group Inc. Appoints New Chief Financial Officer

TORONTO, June 19, 2019 /CNW/ – Target Group, Inc. (“Target Group” or the “Company”) (OTCQB: CBDY) is pleased to announce the appointment of Mr....

Read More

May14th2019

Canary Submits Site Evidence Package to Health Canada Pursuant to Cannabis License Application

Target Group Inc. (OTCQB: CBDY) is pleased to announce that its wholly owned subsidiary, Canary Rx Inc. (“Canary” or the “Company”) has submitted a...

Read More